Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions

导出原文传递

翻译打印收藏纠错

作者： Trog D ^[1] ; Fountoulakis M ^[2] ; Friedlein A ; Golubnitschaja O

作者单位： F Hoffmann La Roche & Co Ltd, Ctr Med Genom, CH-4002 Basel, Switzerland ^[1] Univ Bonn, Dept Radiol, Div Mol Expt Radiol, D-53105 Bonn, Germany ^[2]

关键词 human malignant gliomas pro-invasive activity protein expression patterns therapy conditions RECURRENT GLIOBLASTOMA-MULTIFORME BRAIN-TUMOR PROGRESSION PHASE-II TRIAL EXTRACELLULAR-MATRIX IN-VITRO ANAPLASTIC ASTROCYTOMA GEL-ELECTROPHORESIS ENDOTHELIAL-CELLS RAB9 GTPASE TEMOZOLOMIDE

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Proteomics

2006年6卷9期

2924-2930页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions

Proteomics

相似文献

Proteomics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions

Proteomics

相似文献

Proteomics

相关期刊

检索历史清除